A PHASE-II STUDY OF PIRITREXIM IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

被引:7
作者
DEGARDIN, M
DOMENGE, C
CAPPELAERE, P
LUBOINSKI, B
NAVARRETE, MS
SCOTT, JE
LEFEBVRE, JL
机构
[1] INST GUSTAVE ROUSSY,F-94805 VILLEJUIF,FRANCE
[2] SERV RECH CLIN,LAB WELLCOME,F-92442 ISSY MOULINEAUX,FRANCE
[3] WELLCOME RES LABS,BECKENHAM BR3 3BS,KENT,ENGLAND
关键词
D O I
10.1016/0959-8049(94)90156-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1044 / 1045
页数:2
相关论文
共 11 条
[1]  
ADAMSON PC, 1992, CANCER RES, V52, P521
[2]  
DUCH DS, 1982, CANCER RES, V42, P3987
[3]   PHASE-I TRIAL OF PIRITREXIM CAPSULES USING PROLONGED, LOW-DOSE ORAL-ADMINISTRATION FOR THE TREATMENT OF ADVANCED MALIGNANCIES [J].
FEUN, LG ;
SAVARAJ, N ;
BENEDETTO, P ;
HANLON, J ;
SRIDHAR, KS ;
COLLIER, M ;
RICHMAN, S ;
LIAO, SH ;
CLENDENINN, NJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (01) :51-55
[4]  
MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO
[5]  
2-6
[6]  
SEDWICK WD, 1982, MOL PHARMACOL, V22, P766
[7]  
UEN WC, 1992, CANCER-AM CANCER SOC, V69, P1008, DOI 10.1002/1097-0142(19920215)69:4<1008::AID-CNCR2820690430>3.0.CO
[8]  
2-H
[9]  
VOKES EE, 1991, CANCER-AM CANCER SOC, V67, P2253, DOI 10.1002/1097-0142(19910501)67:9<2253::AID-CNCR2820670907>3.0.CO
[10]  
2-Y